ArticleJournal of clinical medicine2019

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.

Clémence Dubois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.